The gastrointestinal pharmacology of cannabinoids: focus on motility.
about
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationEffects of chronic dietary exposure to monosodium glutamate on feeding behavior, adiposity, gastrointestinal motility, and cardiovascular function in healthy adult rats.Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation.Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat.Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not "higher".The Role of the Endocannabinoid System in the Brain-Gut Axis.Cannabinoids and GI Disorders: Endogenous and Exogenous.Computer vision-based diameter maps to study fluoroscopic recordings of small intestinal motility from conscious experimental animals.Decreased enteric fatty acid amide hydrolase activity is associated with colonic inertia in slow transit constipation.The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice.May cannabinoids prevent the development of chemotherapy-induced diarrhea and intestinal mucositis? Experimental study in the rat.
P2860
Q28079705-DAD79574-BE76-4F6F-8DA0-9033198005CDQ30357558-67E763A6-61F9-435D-A304-9D7BE67FF289Q30989467-53175743-FD2B-48C3-9319-57BE7CFD3765Q34547759-41C9C0F0-F2B2-4918-908E-483BA71C3CE3Q35484505-D73006B5-EC27-4EEA-B62F-25455E44AE4AQ35693020-FC66D262-ACD7-46B6-868E-7941816C4E5EQ36801981-CFDF9AD2-21BC-44AB-A3BF-CEB27A154736Q37032490-1E73416C-53F8-44FE-B26B-96352B1E2269Q37625445-751C8C2E-B16A-46CC-A4AF-E1B8A23A4A1EQ38196875-4639B3F2-7CE4-464F-97D9-45CE7810F49AQ38822341-F47E031C-696B-441D-A6DC-E31AEA8D6720Q38971616-084119B3-7D76-4305-AD64-4BA340C91C77Q47318907-AC9FA005-8643-4A3B-AF3A-9D1849C3F78CQ47829257-F1926ECF-DFDD-4F6A-B5E4-7467E98D66D4Q50975152-5BAA32DE-08A2-49D3-BE07-95A1BEE91C37Q53019346-B31C52DA-1953-4295-97A5-510D7AD73872
P2860
The gastrointestinal pharmacology of cannabinoids: focus on motility.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The gastrointestinal pharmacology of cannabinoids: focus on motility.
@en
type
label
The gastrointestinal pharmacology of cannabinoids: focus on motility.
@en
prefLabel
The gastrointestinal pharmacology of cannabinoids: focus on motility.
@en
P2093
P2860
P356
P1433
P1476
The gastrointestinal pharmacology of cannabinoids: focus on motility.
@en
P2093
Ana Esther López-Pérez
María Isabel Martín-Fontelles
María Martínez-Villaluenga
P2860
P356
10.1159/000339072
P50
P577
2012-06-14T00:00:00Z